DK346385A - GENETIC SEQUENCES INCLUDING CODED INTERFERON PEPTIDES OF TYPE I AND ORGANISMS PRODUCING THESE - Google Patents

GENETIC SEQUENCES INCLUDING CODED INTERFERON PEPTIDES OF TYPE I AND ORGANISMS PRODUCING THESE Download PDF

Info

Publication number
DK346385A
DK346385A DK346385A DK346385A DK346385A DK 346385 A DK346385 A DK 346385A DK 346385 A DK346385 A DK 346385A DK 346385 A DK346385 A DK 346385A DK 346385 A DK346385 A DK 346385A
Authority
DK
Denmark
Prior art keywords
type
sequences including
genetic sequences
including coded
organisms producing
Prior art date
Application number
DK346385A
Other languages
Danish (da)
Other versions
DK175194B1 (en
DK346385D0 (en
Inventor
Rudolf Hauptmann
Peter Meindl
Eva Dworkin-Rastl
Guenther Adolf
Peter Swetly
Christian Pieler
Norbert Hauel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3428370A external-priority patent/DE3428370A1/en
Priority claimed from DE19853505060 external-priority patent/DE3505060A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of DK346385D0 publication Critical patent/DK346385D0/en
Publication of DK346385A publication Critical patent/DK346385A/en
Application granted granted Critical
Publication of DK175194B1 publication Critical patent/DK175194B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)

Abstract

The type I interferon peptides encoded by the genetic DNA sequences are called omega-interferons and are produced using appropriate expression vehicles and organisms.
DK198503463A 1984-08-01 1985-07-30 Recombinant DNA molecules, interferon omega-type genes, transformed hosts containing the DNA information, expression plasmids for interferon-omega types, E. coli transformed therewith, human type I interferons, method ....... DK175194B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3428370 1984-08-01
DE3428370A DE3428370A1 (en) 1984-08-01 1984-08-01 Interferon, genetic sequences which code therefor, and organisms producing these
DE19853505060 DE3505060A1 (en) 1985-02-14 1985-02-14 Type I interferons, genetic sequences which code therefor, and organisms producing these
DE3505060 1985-02-14

Publications (3)

Publication Number Publication Date
DK346385D0 DK346385D0 (en) 1985-07-30
DK346385A true DK346385A (en) 1986-02-02
DK175194B1 DK175194B1 (en) 2004-07-05

Family

ID=25823496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198503463A DK175194B1 (en) 1984-08-01 1985-07-30 Recombinant DNA molecules, interferon omega-type genes, transformed hosts containing the DNA information, expression plasmids for interferon-omega types, E. coli transformed therewith, human type I interferons, method .......

Country Status (21)

Country Link
EP (1) EP0170204B1 (en)
JP (2) JP2566909B2 (en)
KR (1) KR0136799B1 (en)
AT (1) ATE67786T1 (en)
AU (1) AU600653B2 (en)
BG (1) BG60445B2 (en)
CA (1) CA1340184C (en)
DD (1) DD246318A5 (en)
DE (1) DE3584198D1 (en)
DK (1) DK175194B1 (en)
ES (2) ES8609475A1 (en)
FI (1) FI90667C (en)
GR (1) GR851866B (en)
HK (1) HK187896A (en)
HU (1) HU205779B (en)
IE (1) IE58942B1 (en)
IL (1) IL75963A (en)
MX (1) MX9203645A (en)
NO (1) NO177863C (en)
NZ (1) NZ212937A (en)
PT (1) PT80901B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231176A (en) * 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
EP0490233A1 (en) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonal antibodies against Bgl III-hybrid interferons, their use and process for preparing them
DE3607835A1 (en) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int HYBRID INTERFERONS, THEIR USE AS MEDICINAL PRODUCTS AND AS INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF ANTIBODIES AND THE USE THEREOF AND METHOD FOR THEIR PRODUCTION
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
DE3633323A1 (en) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int NEW MONOCLONAL ANTIBODIES AGAINST IFN-OMEGA, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR CLEANING AND DETECTING IFN-OMEGA
DE3635867A1 (en) * 1986-10-22 1988-05-11 Boehringer Ingelheim Int NEW YEAR EXPRESSION VECTORS FOR IFN-OMEGA, METHOD FOR THEIR PRODUCTION AND USE THEREOF
CA2641217A1 (en) 1997-11-20 1999-06-03 Vical Incorporated Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
WO2000040273A2 (en) * 1999-01-08 2000-07-13 Vical Incorporated Treatment of viral diseases using an interferon omega expressing polynucleotide
ATE317897T1 (en) 2002-03-07 2006-03-15 Eidgenoess Tech Hochschule SYSTEM AND METHOD FOR PRODUCING RECOMBINANT GLYCOSYLATED PROTEIN IN PROKARYONTIC HOST CELLS
KR100938026B1 (en) * 2002-03-07 2010-01-21 아이드게노쉬쉐 테흐니쉐 호흐슐레 쥬리히 System and method for the production of recombinant glycosylated protein in a prokaryotic host
JP4674702B2 (en) 2003-04-09 2011-04-20 バイオジェネリクス エージー Glycopegylation method and protein / peptide produced by the method
WO2004096852A1 (en) * 2003-04-25 2004-11-11 The Institute Of Microbiology And Epidemiology, Academy Of Military Medical Sciemces, Pla A RECOMBINANT HUMAN INTERFERON ϖ, THE METHOD FOR EXPRESSING IT AND THE USES OF IT
PL2311972T3 (en) 2005-05-11 2015-08-31 Eth Zuerich Recombinant N-glycosylated proteins from procaryotic cells
PL2257307T3 (en) 2008-02-20 2018-11-30 Glaxosmithkline Biologicals S.A. Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
EP2501406B8 (en) 2009-11-19 2018-01-24 GlaxoSmithKline Biologicals S.A. Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells
CN103079591B (en) 2010-05-06 2017-07-28 格林考瓦因有限公司 Capsular gram-positive bacteria bioconjugate vaccine
WO2013024158A1 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of protein kinase inhibitors and interferons or of protein kinase inhibitors and direct acting antivirals for the treatment and the prevention of hcv infection
WO2013024156A2 (en) 2011-08-17 2013-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Combinations of anti-hcv-entry factor antibodies and interferons for the treatment and the prevention of hcv infection
WO2014033266A1 (en) 2012-08-31 2014-03-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-sr-bi antibodies for the inhibition of hepatitis c virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1217440A (en) * 1982-08-18 1987-02-03 Michael A. Innis INTERFERON .alpha. 6L
AU1946283A (en) * 1982-08-18 1984-03-07 Cetus Corporation Interferon-alpha 6l
DE3247922A1 (en) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim DNA SEQUENCES, THEIR PRODUCTION, PLASMIDES CONTAINING THESE SEQUENCES AND THE USE THEREOF FOR THE SYNTHESIS OF EUKARYOTIC GENE PRODUCTS IN PROKARYOTS
EP0174143B1 (en) * 1984-08-27 1989-11-08 Genentech, Inc. Novel, distinct family of human leukocyte interferons, compositions containing them, methods for their production, and dna and transfected hosts therefor

Also Published As

Publication number Publication date
ES552431A0 (en) 1987-09-01
MX9203645A (en) 1992-09-01
JPS61181381A (en) 1986-08-14
FI90667B (en) 1993-11-30
DK175194B1 (en) 2004-07-05
CA1340184C (en) 1998-12-15
JP2566909B2 (en) 1996-12-25
EP0170204A2 (en) 1986-02-05
AU600653B2 (en) 1990-08-23
IE58942B1 (en) 1993-12-01
ES545725A0 (en) 1986-08-01
IE851906L (en) 1986-02-01
DK346385D0 (en) 1985-07-30
EP0170204A3 (en) 1988-02-17
ES8609475A1 (en) 1986-08-01
NO177863C (en) 1995-12-06
JPH06181771A (en) 1994-07-05
DD246318A5 (en) 1987-06-03
KR0136799B1 (en) 1998-04-25
HK187896A (en) 1996-10-18
GR851866B (en) 1985-12-02
KR870001310A (en) 1987-03-13
PT80901B (en) 1989-01-17
ATE67786T1 (en) 1991-10-15
HU205779B (en) 1992-06-29
AU4554985A (en) 1986-02-06
PT80901A (en) 1985-09-01
JP2567195B2 (en) 1996-12-25
IL75963A0 (en) 1985-12-31
NZ212937A (en) 1991-08-27
FI90667C (en) 1994-03-10
IL75963A (en) 1992-05-25
DE3584198D1 (en) 1991-10-31
ES8708013A1 (en) 1987-09-01
FI852956A0 (en) 1985-07-31
NO177863B (en) 1995-08-28
FI852956L (en) 1986-02-02
HUT39477A (en) 1986-09-29
EP0170204B1 (en) 1991-09-25
NO853012L (en) 1986-02-03
BG60445B2 (en) 1995-03-31

Similar Documents

Publication Publication Date Title
DK346385A (en) GENETIC SEQUENCES INCLUDING CODED INTERFERON PEPTIDES OF TYPE I AND ORGANISMS PRODUCING THESE
DE69518751T2 (en) PURIFIED SCYTALIDIUM LACASSES AND NUCLEIC ACIDS CODING THEM
ATE112802T1 (en) PRODUCTION OF FUNCTIONAL HUMAN UROKINASEPOLYPEPTIDES.
DE3587864T2 (en) RECOMBINANT DNA MOLECULES.
DK494681A (en) FIVE-METHOD OF MANUFACTURING INTERFERONES
DE3576524D1 (en) DNA SEQUENCES.
DE69030615T2 (en) New polypeptides, DNA sequences that allow their expression, preparation and use methods
DE3787112T2 (en) Human pancreatic elastase I.
DK38889A (en) ONCOGEN-ENCODED POLYPEPTIDE WITH GROWTH FACTOR ACTIVITY
ATE35427T1 (en) RECOMBINANT DNA, MICROORGANISM TRANSFORMED WITH IT AND USE THEREOF.
ATE175237T1 (en) POLYPEPTIDES INVOLVED IN COBALAMINE AND/OR COBAMIDE BIOSYNTHESIS, FOR THESE DNA SEQUENCES CODING, AND THEIR PRODUCTION AND USE.
SG134394G (en) Genetic sequences, type I interferon peptide coded by them, and these organisms producing the same
ATE110112T1 (en) METHODS AND SYSTEMS FOR THE PRODUCTION OF HIV ANTIGENS.
ATE83800T1 (en) RECOMBINANT DNA PLAMID FOR THE PRODUCTION OF XANTHAN GUM.

Legal Events

Date Code Title Description
PUP Patent expired